A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis

Cattran, 2002, Membranous nephropathy: quo vadis?, Kidney Int, 61, 349, 10.1046/j.1523-1755.2002.00125.x Schieppati, 1993, Prognosis of patients with idiopathic membranous nephropathy, N Engl J Med, 329, 85, 10.1056/NEJM199307083290203 Honkanen, 1992, Natural history, clinical course and morphological evolution of membranous nephropathy, Nephrol Dial Transplant, 7, 35 Ponticelli, 1998, A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy, J Am Soc Nephrol, 9, 444, 10.1681/ASN.V93444 Cattran, 1995, A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group, Kidney Int, 47, 1130, 10.1038/ki.1995.161 Praga, 2007, Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial, Kidney Int, 71, 924, 10.1038/sj.ki.5002215 Cravedi, 2014, Rituximab in primary membranous nephropathy: first-line therapy, why not?, Nephron Clin Pract, 128, 261, 10.1159/000368589 Westhoff, 2007, Tacrolimus in the treatment of idiopathic nephrotic syndrome, Expert Opin Investig Drugs, 16, 1099, 10.1517/13543784.16.7.1099 Gupta, 2007, A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy, J Am Soc Nephrol, 18, 1899, 10.1681/ASN.2007020166 Faurschou, 2008, Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients, J Rheumatol, 35, 100 Xu, 2013, Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial, Contrib Nephrol, 181, 152, 10.1159/000348475 He, 2013, Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids, J Nephrol, 26, 564, 10.5301/jn.5000199 Chen, 2010, Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial, Am J Med Sci, 339, 233, 10.1097/MAJ.0b013e3181ca3a7d Li, 2008, Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria, J Nephrol, 21, 584 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Ramachandran, 2017, Two-year follow-up study of membranous nephropathy treated with tacrolimus and corticosteroids versus cyclical corticosteroids and cyclophosphamide, Kidney Int Rep, 2, 610, 10.1016/j.ekir.2017.02.004 Ramachandran, 2016, Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: randomized control trial, Nephrology (Carlton), 21, 139, 10.1111/nep.12569 Peng, 2016, Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy, J Formos Med Assoc, 115, 11, 10.1016/j.jfma.2015.07.021 Mathieson, 1988, Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function, Lancet, 2, 869, 10.1016/S0140-6736(88)92470-1 Ronco, 2012, Pathogenesis of membranous nephropathy: recent advances and future challenges, Nat Rev Nephrol, 8, 203, 10.1038/nrneph.2012.35 Pozdzik, 2018, Membranous nephropathy and anti-podocytes antibodies: implications for the diagnostic workup and disease management, Biomed Res Int, 2018, 6281054, 10.1155/2018/6281054 Segal, 2012, Recent advances and prognosis in idiopathic membranous nephropathy, Adv Chronic Kidney Dis, 19, 114, 10.1053/j.ackd.2012.01.007 Podracka, 2013, [Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis)], Vnitr Lek, 59, 113 Yuan, 2011, Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study, Nephrology (Carlton), 16, 440, 10.1111/j.1440-1797.2010.01427.x Laluck, 1999, Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy, Am J Kidney Dis, 33, 1026, 10.1016/S0272-6386(99)70138-1 Troyanov, 2004, Idiopathic membranous nephropathy: definition and relevance of a partial remission, Kidney Int, 66, 1199, 10.1111/j.1523-1755.2004.00873.x Sinha, 2006, Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus, Nephrol Dial Transplant, 21, 1848, 10.1093/ndt/gfi274 Cattran, 2017, Membranous nephropathy: integrating basic science into improved clinical management, Kidney Int, 91, 566, 10.1016/j.kint.2016.09.048 Ronco, 2015, Pathophysiological advances in membranous nephropathy: time for a shift in patient's care, Lancet, 385, 1983, 10.1016/S0140-6736(15)60731-0 Francis, 2016, Membranous nephropathy: a journey from bench to bedside, Am J Kidney Dis, 68, 138, 10.1053/j.ajkd.2016.01.030 Hofstra, 2012, Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy, J Am Soc Nephrol, 23, 1735, 10.1681/ASN.2012030242 Hofstra, 2014, Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues, J Am Soc Nephrol, 25, 1137, 10.1681/ASN.2014010091 Kanigicherla, 2013, Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy, Kidney Int, 83, 940, 10.1038/ki.2012.486 Beck, 2013, KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis, Am J Kidney Dis, 62, 403, 10.1053/j.ajkd.2013.06.002 Hofstra, 2010, Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial, Nephrol Dial Transplant, 25, 129, 10.1093/ndt/gfp390 Song, 2017, Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: a network meta-analysis, PLOS ONE, 12, e0184398, 10.1371/journal.pone.0184398